Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

por Ben-David, Uri
Publicado 2013

A balancing act: how whole-genome doubling and aneuploidy interact in human cancer

por Prasad, Kavya, Ben-David, Uri
Publicado 2023

Genome maintenance in pluripotent stem cells

por Weissbein, Uri, Benvenisty, Nissim, Ben-David, Uri
Publicado 2014

Aneuploid senescent cells activate NF‐κB to promote their immune clearance by NK cells

por Wang, Ruoxi W, Viganò, Sonia, Ben‐David, Uri, Amon, Angelika, Santaguida, Stefano
Publicado 2021

Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer

por Abdeen, Suhaib K., Ben-David, Uri, Shweiki, Aya, Maly, Bella, Aqeilan, Rami I.
Publicado 2018

Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations

por Chang, Tian-Gen, Cao, Yingying, Shulman, Eldad D., Ben-David, Uri, Schäffer, Alejandro A., Ruppin, Eytan
Publicado 2023

The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis

por Ben-David, Uri, Ha, Gavin, Khadka, Prasidda, Jin, Xin, Wong, Bang, Franke, Lude, Golub, Todd R.
Publicado 2016

FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation

por Vaz, Sara, Ferreira, Fábio J., Macedo, Joana C., Leor, Gil, Ben-David, Uri, Bessa, José, Logarinho, Elsa
Publicado 2021

DNA-based copy number analysis confirms genomic evolution of PDX models

por Hoge, Anna C. H., Getz, Michal, Zimmer, Anat, Ko, Minjeong, Raz, Linoy, Beroukhim, Rameen, Golub, Todd R., Ha, Gavin, Ben-David, Uri
Publicado 2022

Publisher Correction: DNA-based copy number analysis confirms genomic evolution of PDX models

por Hoge, Anna C. H., Getz, Michal, Zimmer, Anat, Ko, Minjeong, Raz, Linoy, Beroukhim, Rameen, Golub, Todd R., Ha, Gavin, Ben-David, Uri
Publicado 2022

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients

por Sacconi, Andrea, Muti, Paola, Pulito, Claudio, Urbani, Giulia, Allegretti, Matteo, Pellini, Raul, Mehterov, Nikolay, Ben-David, Uri, Strano, Sabrina, Bossi, Paolo, Blandino, Giovanni
Publicado 2023

Patient-derived xenografts undergo murine-specific tumor evolution

por Ben-David, Uri, Ha, Gavin, Tseng, Yuen-Yi, Greenwald, Noah F., Oh, Coyin, Shih, Juliann, McFarland, James M., Wong, Bang, Boehm, Jesse S., Beroukhim, Rameen, Golub, Todd R.
Publicado 2017

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

por Enache, Oana M., Rendo, Veronica, Abdusamad, Mai, Lam, Daniel, Davison, Desiree, Pal, Sangita, Currimjee, Naomi, Hess, Julian, Pantel, Sasha, Nag, Anwesha, Thorner, Aaron R., Doench, John G., Vazquez, Francisca, Beroukhim, Rameen, Golub, Todd R., Ben-David, Uri
Publicado 2020

Acute expression of human APOBEC3B in mice results in RNA editing and lethality

por Alonso de la Vega, Alicia, Temiz, Nuri Alpay, Tasakis, Rafail, Somogyi, Kalman, Salgueiro, Lorena, Zimmer, Eleni, Ramos, Maria, Diaz-Jimenez, Alberto, Chocarro, Sara, Fernández-Vaquero, Mirian, Stefanovska, Bojana, Reuveni, Eli, Ben-David, Uri, Stenzinger, Albrecht, Poth, Tanja, Heikenwälder, Mathias, Papavasiliou, Nina, Harris, Reuben S., Sotillo, Rocio
Publicado 2023

Short-term molecular consequences of chromosome mis-segregation for genome stability

por Garribba, Lorenza, De Feudis, Giuseppina, Martis, Valentino, Galli, Martina, Dumont, Marie, Eliezer, Yonatan, Wardenaar, René, Ippolito, Marica Rosaria, Iyer, Divya Ramalingam, Tijhuis, Andréa E., Spierings, Diana C. J., Schubert, Michael, Taglietti, Silvia, Soriani, Chiara, Gemble, Simon, Basto, Renata, Rhind, Nick, Foijer, Floris, Ben-David, Uri, Fachinetti, Daniele, Doksani, Ylli, Santaguida, Stefano
Publicado 2023

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting

por Stossel, Chani, Raitses-Gurevich, Maria, Atias, Dikla, Beller, Tamar, Glick Gorman, Yulia, Halperin, Sharon, Peer, Eyal, Denroche, Robert E., Zhang, Amy, Notta, Faiyaz, Wilson, Julie M., O'Kane, Grainne M., Haimov Talmoud, Elina, Amison, Nora, Schvimer, Michael, Salpeter, Seth J., Bar, Vered, Zundelevich, Adi, Tirosh, Itay, Tal, Rotem, Dinstag, Gal, Kinar, Yaron, Eliezer, Yonatan, Ben-David, Uri, Gavert, Nancy S., Straussman, Ravid, Gallinger, Steven J., Berger, Raanan, Golan, Talia
Publicado 2023

Genetic and transcriptional evolution alters cancer cell line drug response

por Ben-David, Uri, Siranosian, Benjamin, Ha, Gavin, Tang, Helen, Oren, Yaara, Hinohara, Kunihiko, Strathdee, Craig A., Dempster, Joshua, Lyons, Nicholas J., Burns, Robert, Nag, Anwesha, Kugener, Guillaume, Cimini, Beth, Tsvetkov, Peter, Maruvka, Yosef E., O’Rourke, Ryan, Garrity, Anthony, Tubelli, Andrew A., Bandopadhayay, Pratiti, Tsherniak, Aviad, Vazquez, Francisca, Wong, Bang, Birger, Chet, Ghandi, Mahmoud, Thorner, Aaron R., Bittker, Joshua A., Meyerson, Matthew, Getz, Gad, Beroukhim, Rameen, Golub, Todd R.
Publicado 2018

A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling

por Altea-Manzano, Patricia, Doglioni, Ginevra, Liu, Yawen, Cuadros, Alejandro M., Nolan, Emma, Fernández-García, Juan, Wu, Qi, Planque, Mélanie, Laue, Kathrin Julia, Cidre-Aranaz, Florencia, Liu, Xiao-Zheng, Marin-Bejar, Oskar, Van Elsen, Joke, Vermeire, Ines, Broekaert, Dorien, Demeyer, Sofie, Spotbeen, Xander, Idkowiak, Jakub, Montagne, Aurelie, Demicco, Margherita, Alkan, H Furkan, Rabas, Nick, Riera-Domingo, Carla, Richard, François, Geukens, Tatjana, De Schepper, Maxim, Leduc, Sophia, Hatse, Sigrid, Lambrechts, Yentl, Kay, Emily Jane, Lilla, Sergio, Alekseenko, Alisa, Geldhof, Vincent, Boeckx, Bram, de la Calle Arregui, Celia, Floris, Giuseppe, Swinnen, Johannes V., Marine, Jean-Christophe, Lambrechts, Diether, Pelechano, Vicent, Mazzone, Massimiliano, Zanivan, Sara, Cools, Jan, Wildiers, Hans, Baud, Véronique, Grünewald, Thomas G.P., Ben-David, Uri, Desmedt, Christine, Malanchi, Ilaria, Fendt, Sarah-Maria
Publicado 2023